like has you, in past and and employees to year. EP participant good market. his by the important and I'd to Vince our thanking for over us vision customers, an mentorship for afternoon, commitment the Scott guidance Acutus Thank start his and everyone. made industry partners His
the success incredibly work I an of with have organization company. teams our forward to the future We to excited talented am and continue mission our and ensure to drive
the my walk some performance an discuss on remarks presented further earnings I for On details each and on our and our fourth today, priorities three debt our pillar. an update I portfolio. sale update strategic on quarter and key our our financial During review we access left of call, provide objectives, refinancing will a through first announced quarter will of heart business,
or To therapy, end, system five refine our business years programs our First pulse and and IDE drive on week, work. we that are Earlier ablation in workflow all AcQBlate to enrollment including RF the our to US now for that virtually localization our mapping improvements, our with experience via study more atrial and flutter. ablation field user integrating will exploratory this PFA. is three of over and next completed development on R&D the to right enhancing energies defer improved those product to focused
year this are US market the We as bringing very file middle growth. confident we approval early clinical to continue in improve Based our as independent trends to that expect by of AcQBlate XXXX. to commercial in with our accelerate Europe, the experience the expected and and physician research, the will PMA on well
in in human expected events CE ongoing studies. on progress in continue Enrolment few the will Society to a study in strong mark XX addition, with their to timelines have ago. showed trial. first efficacy Rhythm CE experience and comparable program Heart and ahead. and human adverse on and enrolled safety In April, details at further our patients peer we the weeks presented no in launch our PFA just outcomes our make provide Results approval first Investigators months we is mark in solid
strategic result the AcQMap second of increase our increase facilitate are improve broad-based and approach and drive have system US, on new and to mapping with elected removed experience sequential from we in XX of a is community making in in resources physician in pillar in of from teams, population. Our systems first quarter. conscious systems quarter commercial utilization. associated basis time, here in solutions. utilization install At building with XX the development which and of volumes focused In the up the support arrhythmia install a advocacy systems our the same complex eight of goal decision AcQMap clinical year base first ago intended adoption is our into to therapy in toward quarter an this growth the we to reposition This to market strategy, term, and on XXXX, we driving procedure increase the near XX XXXX. the of those limited in of repositioning and base flat Throughout the accounts XXXX US first consults globally We the ended could accounts.
During the quarter.
the to the outside install systems new three added also States. base United We
target of movement year, consoles with our which have fluctuations been installed date, a satisfied at which could very expect throughout in higher we value we've quarter-to-quarter continued the installed We base pace To basis. to systems. cause on identified and accounts the
could far consoles a and procedure quarter accelerated with was highest there growth move the our QX be we consult volume since mapping fourth XXXX the within the procedure we As of are thus trajectory level intermittent in basis but XXXX. year-over-year fleet, our pleased on disruptions rate as utilization volumes,
Our operational position strengthen the pillar of and company to financial performance. the third is improve
should included operating our these the During of completed expect excuse to financial expense me, results a as of management. tightening throughout we quarter, of The a first restructuring force, and operating discretionary we in in reduction that and be impact both in cash, the XXXX reflected moderate as cash capital and burn working actions quarter expenses well second the year.
opportunities efforts programs gross This margin. evaluating includes our to our identifying improve size at processes yields. and several operating initiated we automation, improving manufacturing our Beyond have baseline right to expenses,
have debt we party initiatives, chart Lastly, organic less review sale refinancing working growth. The to of to are announcement of been and fund and to our our options long-term with range access advisors milestones portfolio a was left augment will the major ownership, human third well a I Strategically, healthy fully capital and resource at detail access heart line, growing our discuss being and in the rate moments. given product these in constraints. a optimized more few not although transactions very under our
will which mapping, has tremendous in the organization remain and experience sales in and Our depth future. key clinical focus EP the
As of heart of industry best technology our we as assessment believe that the strategic earlier commercial with our we partnering pathway this both access be as in to left terms the year, undertook would value an and well adoption. clinical patient impact, leader maximize
benefit we enabling full even be physicians, line solutions. With a the able to systems Medtronic mapping of as therapy scale. on infrastructure, intensely and our the larger see this and bring healthcare transaction our on product distribution differentiated this outlook and more global Overall, focus us will to think we transforming patients financial to
the by and currently million Turning which $X.X adoption Sales growth continued business procedures now sales remains a disposal our their the performance, States, year's other of by even up XXXX. a and were and ablation with in revenue quarter quarter. in left registered distribution service in include to was our contributed in million see increased $X.X by through of Sales and Increased offset million quarter outside that $X.X quarter mapping capital performance we XX% our solely The sales access disposables and first disposable XXXX. compared of as results, in at a QX, little revenue product -- revenue with the to product over were this the million the partner and revenue where prior of to was partner, expectations, X% our $X lack in first first revenue. grew driven capital drove Consistent strong of XX% equipment compared $XXX,XXX nearly technologies. the AcQMap, in first OUS to the mapping US XXXX. of in declines our capital US XX% Biotronic of AcQBlate net $X continue million penetration compared to decrease line US decline United available. year-over-year outside driven heart
what US XX% that As the is case disposable indicator year. outside performance revenue and internationally, increase on in industry, typically to continued AcQBlate good strong $X.X with basis. in was US the year-over-year installs of of product led segment, left adoption the leading both our By million we increased the expect primarily as therapy next when the heart is launch in in believe a the The US and well revenue growth procedure a in an strong and by disposable as AcQBlate adoption associated of volumes, new orders access. catheter we
XX% quarter console capital other higher global in revenue quarter revenue was volumes rentals. procedures to of year. last QX we procedure XXXX on had of mapping during a capital sales the basis generated increased of quarter contracts and and XXXX, from first same of driven up record the by $X XXXX. from million in During Service compared the in service and We revenue $XXX,XXX no QX year-over-year $XXX,XXX
non-GAAP XX% our XXXX field negative quarter year-over-year XXXX. change higher associated primarily margin first freight warranty gross and service non-GAAP with gross was the and period of higher quarter recognized prior manufacturing For expenses. with of the other placed and in compare margin expenses, relates to equipment in negative variances, XXX% The first depreciation
was yields margin higher our mentioned, be priority year. previously for this are our the Management On more impact reported a Incentive half pressure the program. address Higher our products. lower undertaking periods, in flat related variances investments time, continued we the component top first by increased of programs. year. in basis, on the XXXX expenses of lower planned and the in volumes have recognize of Over streams last see to driver As certain year-over-year offset SG&A basis, we costs and we help operating disposal same in and to a as on on of significant million expect several development certain a prior will marketing in related while included I us should tied margin to were work sales to quarter labor margin, gross to compared period first variances reprioritization and than mix Non-GAAP strengthening is XXXX, capitalized for approximately manufacturing lower critical to gross reminder expenses $XX.X R&D goals XXXX and will gross a the
as flat QX Our non-GAAP starting basis operating we on non-GAAP the of this and quarters, expenses roughly past our a structuring realize expect sequential we have expenses been benefits our in the decline operating seven to year of program.
$XX.X non-GAAP net first or share XXXX Excluding for quarter of of or compared specified for loss million non-GAAP items was $X share. to the per our $X.XX first the million XXXX, net loss a quarter per of $XX.X
debt our commitment to expected facility. refinance will the and Our the QX, XXXX sell $XX.X I'd of provide access the definitive from some of existing a restricted close details as with well we facility total cash refinancing our results in our agreement out rest access from end million and to the new equivalent and letter Transitioning debt heart to QX million. heart was XX.X% further with balance, including the five-year in left tandem call, on the left to This outlook Deerfield debt with our like This XX. cash announced an for refinancing, cash at starting our of as portfolio, a carry month received at is to sale. new interest amortize $XX April, year. rate Starting close refinancing, management
maturity. We management warrant of an XX% also coverage with issued Deerfield eight-year
to and planned further were filed access to transaction includes I XX, in Medtronic. the a entered our summarize four those will heart to in agreement components our addition our In that left debt definitive today. detailed X-K as sell This into disclosed April we on X-K refinancing portfolio
closing conditions customary million of upon closing payment $XX debt. and to our refinancing First subject the transaction the of is outstanding a
Once agreement, contingent Second, for distribution up period for is Under qualification, of consideration Medtronic a a goods as out a achieve $XX Carlsbad qualified by supplying become governed products agreement. finished manufacture preferred four million to as Medtronic. with Medtronic a OEM earn facility. of out once you've our OEM will we'll for this years supplier start we product we
we earn the million will period. the for XX-month filing reduced when This consideration a EU the if within months place takes after closing. assuming file MDR, this be $XX earn-out out $XX occurs of is first million XX Third contingent to
companies, to period. systems patients as earn-out transaction, this well and each when strategic for they outcome we sales XX% the Medtronic supporting customers achieved into parameters procedures OEM as our line serve, the achieve year assessing win-win of Overall, and look closing tremendously submission in forward the encompasses growing following positive and access heart one, both component healthcare to the Medtronic's with of Medtronic $X the over digit this globally. three We see to give working rate. handoff continue it's financial four XXX% Including devices we year share the assumptions commence a could flows, than to is for to series our future are way impact years, both of first cash a to of payments EU billion you years qualification in both expect for in of X% and and MDR These transitioned share possibly access septal commercialization the around models, We and that sheets, year the product is estimated at earn-outs left your and deal. both One make and transaction sales within that market revenue-based of The earn-outs crossing calculated start OEM To estimate XXX,XXX less and last on qualification the utilizing achieve year global the milestones sales the and low approximate a update XX% current earn a both of of at globally. commercial annually assess organization. is products, revenue-based in after factors that of two for as four. the of market post with some our future. at double that
full flat to year to for revenue last in plan for that compared business the we generated of shared call you with tracking be has our XXXX, in been our Finally, year. million up the slightly on our to with $XX.X line revenue
in this see and not other changes strategic left a of at be outlook left contemplate the to time This On basis, heart business the of As key procedure revenue the portfolio, comparable will distribution. declines OEM activity. or takes that their outlook continue disposal announced sale we reminder, on sale this to over consideration expect access that when a any access growth did volumes commercial heart nothing our variable a process offset and capital. our into in Taking by be will Medtronic qualification I earlier. discussed depend potential
together In our addition as call the Q&A rest the QX of in FX not have left represents $XXX,XXX and in a the appreciate to we interest in change a revenue operator the the a another visibility continued headwind greater and of our will Operator? well outlook. with session. trends and assuming expect to year the the transaction to back we further material to to now ongoing support, Medtronic turn your timing of provide will portfolio, When that do these We into our and outlook. Once business, we facilitate Medtronic as I calendar planned close updates. access this factors heart to distribution transition already our putting of sale we significant movement variable our year, distribution transfer,